REVIEW PAPER
Pre-quitting nicotine replacement therapy: Findings from a pilot study
 
More details
Hide details
1
Clinical Trials Research Unit, University of Auckland, Auckland, New Zealand
2
National Addiction Centre, Christchurch School of Medicine, University of Otago, Christchurch, New Zealand
Publish date: 2006-08-15
 
Tobacco Induced Diseases 2006;3(August):35
KEYWORDS
ABSTRACT
Background:
Using nicotine replacement therapy (NRT) while still smoking in the lead up to quitting could enhance success at quitting, one of the most cost-effective means of improving health, but little is known about its acceptability and tolerability.

Aim:
To test the acceptability and tolerability of using NRT while smoking for two weeks before quitting, to inform a randomised controlled trial of pre-quitting NRT versus usual NRT-based quitting practice.

Methods:
Prospective pragmatic uncontrolled clinic-based pilot study in which 14 adult smokers recruited from a smoking cessation clinic were prescribed nicotine patches or gum with follow up for two weeks. Data were collected on participants' concerns about smoking while using NRT, importance of quitting, urges to smoke, smoking behaviour, previous NRT use and the length of the pre-quitting period. Urine tests were collected weekly for cotinine, and participants recorded smoking activity and noted experiences and changes in their health in diaries.

Results:
Only 21% of 14 participants expressed concerns about using NRT while smoking. All of the nine followed up used it as recommended, 56% of these reporting no unpleasant symptoms. Median urine cotinine levels declined over the two weeks. Urges to smoke averaged 1.8 on a 4-point scale. All participants decreased the number of cigarettes per day. Diary records showed wide variation in smoking and NRT use, with an increased sense of control and determination to quit.

Conclusion:
Smokers using pre-quitting NRT over two weeks appeared to titrate nicotine levels and symptoms of toxicity were uncommon and of low intensity.

 
REFERENCES (12)
1.
Silagy C, Lancaster T, Stead L, Mant D, Fowler G: Nicotine replacement therapy for smoking cessation. Cochrane Database Systematic Reviews. 2004, 3: CD000146.
 
2.
Herrera N, Franco R, Herrera L, Partidas A, Rolando R, Fagerstrom KO: Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program. Chest. 1995, 108: 447-451. 10.1378/chest.108.2.447.
 
3.
Schuurmans MM, Diacon AH, van Biljon X, Bolliger CT: Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial. Addiction. 2004, 99: 634-640. 10.1111/j.1360-0443.2004.00711.x.
 
4.
Hughes JR, Hatsukami D: Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry. 1986, 43 (3): 289-294.
 
5.
Fagerstrom K, Hughes J: Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: a review. Nicotine and Tobacco Research. 2002, 4 (Suppl 2): S73-S79. 10.1080/1462220021000032753.
 
6.
Bandura A: Self-efficacy: toward a unifying theory of behavioural change. Psychological Review. 1977, 84: 191-215. 10.1037/0033-295X.84.2.191.
 
7.
Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB, Predicting smoking cessation: Who will quit with and without the nicotine patch. Journal of the American Medical Association. 1994, 271 (8): 589-594. 10.1001/jama.271.8.589.
 
8.
Russell M: Nicotine intake and its regulation by smokers. Tobacco smoking and nicotine: a neurobiological approach. Edited by: Martin WR VLG, Iwamoto ET, Davis L. 1987, New York: Plenum Press, 31.
 
9.
Foulds J, Stapleton J, Feyerabend C, Vesey C, Jarvis M, Russell MA: Effect of transdermal nicotine patches on cigarette smoking: a double blind crossover study. Psychopharmacology. 1992, 106: 421-427. 10.1007/BF02245429.
 
10.
Russell MA, Feyerabend C, Cole PV: Plasma nicotine levels after cigarette smoking and chewing nicotine gum. British Medical Journal. 1976, 1: 1043-1046. 10.1136/bmj.1.6017.1043.
 
11.
Ebert RV, McNabb ME, Snow SL: Effect of nicotine chewing gum on plasma nicotine levels of cigarette smokers. Clinical and Pharmacology Therapy. 1984, 35: 495-498.
 
12.
Benowitz N, Jacob P, Jones R, Rosenberg J: Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. Journal of Pharmacy and Pharmacology Experimental Therapy. 1982, 221: 368-372.
 
 
CITATIONS (3):
1.
New Methods for Tobacco Dependence Treatment Research
Timothy B. Baker, Robin Mermelstein, Linda M. Collins, Megan E. Piper, Douglas E. Jorenby, Stevens S. Smith, Bruce A. Christiansen, Tanya R. Schlam, Jessica W. Cook, Michael C. Fiore
Annals of Behavioral Medicine
 
2.
Strategies for smoking cessation: what is new and what works?
K Michael Cummings, Martin C Mahoney
Expert Review of Respiratory Medicine
 
3.
Initial puffing behaviors and subjective responses differ between an electronic nicotine delivery system and traditional cigarettes
Kaila J Norton, Kristie M June, Richard J O’Connor
Tobacco Induced Diseases
 
eISSN:1617-9625